Sign in

CIK 0001287098

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

MAXCYTE, INC.

Sign in to watch
Ticker
MXCT
Exchange
Nasdaq
Industry
Services-Commercial Physical & Biological Research
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
522210438
Phone
+1 301-517-5556
Business address
9713 KEY WEST AVENUE,, SUITE 400, ROCKVILLE, MD, 20850
Former names
MAXCYTE INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2021-08-09 Masoud Maher EVP and General Counsel Grant or award · Stock Option (right to buy) +10,000 10,000
2021-08-09 Mandell Art Director Grant or award · Stock Option (right to buy) +10,000 10,000
2021-08-09 Johnston John Joseph Director Grant or award · Stock Option (right to buy) +10,000 10,000
2021-08-09 Holtz Ron SVP and CAO Grant or award · Stock Option (right to buy) +10,000 10,000
2021-08-09 Hemrajani Rekha Director Grant or award · Stock Option (right to buy) +10,000 10,000
2021-08-09 Erck Stanley C Director Grant or award · Stock Option (right to buy) +10,000 10,000
2021-08-09 DOUGLAS RICHARD Director Grant or award · Stock Option (right to buy) +10,000 10,000
2021-08-09 Doerfler Douglas President and CEO Grant or award · Stock Option (right to buy) +10,000 10,000
2021-08-09 Brooke William W Director Grant or award · Stock Option (right to buy) +10,000 10,000
2021-08-09 Al-Wakeel Yasir B. Director Grant or award · Stock Option (right to buy) +10,000 10,000
2021-07-30 Casdin Partners Master Fund, L.P. 10% owner Purchase +1,800,000 $13.00 $23.4M 13,971,334

Page 21 of 21 · 411 trades